Simoes, R D M, Shirasaki, R, Downey-Kopyscinski, S L, Matthews, G, Yiguo, H, Sheffer, M, Dhimolea, E, Dashevsky, O, Gandolfi, S, Dempster, J, Meyers, R M, Bryan, J, McFarland, J M, Brueggenthies, J, Tang, H, Bariteau, M, Borah, M, Sievers, Q L, Ebert, B, Glassner, B, Ott, C J, Kwiatkowski, N P, Doench, J G, Auclair, D, Levy, J, Boise, L H, Keats, J J, Licht, J D, Groen, R, Gray, N, Culhane, A, Hahn, W C, Vazquez, F, Tsherniak, A & Mitsiades, C S 2019, ' Systematic Characterization of Genes Representing Preferential Molecular Vulnerabilities for Myeloma Cells Compared to Other Neoplasias-Implications for the Biology and Therapeutic Targeting of Myeloma ', Blood, vol. 134 . https://doi.org/10.1182/blood-2019-130901 Blood, 134. American Society of Hematology
Shirasaki, R, Simoes, R D M, Downey-Kopyscinski, S, Matthews, G, Hu, Y, Sheffer, M, Dhimolea, E, Dashevsky, O, Gandolfi, S, Hengeveld, P, Dempster, J, Meyers, R, Bryan, J, Dharia, N, McFarland, J, Sarkar, S, Bruggenthies, J, Tang, H, Bariteau, M, Aguirre, A, Borah, M, Sievers, Q, Ebert, B, Raja, J, Glassner, B J, Ott, C, Bradner, J, Kwiatkowski, N, Auclair, D, Levy, J, Poarch, H, Zhang, T, Laubach, J, Buckley, D, Schlossman, R, Groen, R, Fischer, E, Richardson, P G, Keats, J, Boise, L, Licht, J, Culhane, A, Gray, N, Hahn, W, Vazquez, F, Tsherniak, A & Mitsiades, C 2019, ' CRISPR studies identify genes preferentially essential for myeloma cells vs. other neoplasias: implications for future therapies selective against MM ', Clinical Lymphoma Myeloma and Leukemia, vol. 19, no. 10, pp. E48-E49 . Clinical Lymphoma Myeloma and Leukemia, 19(10), E48-E49. Cancer Media Group